News & Press Releases
Filter by:
Mintz Completes $24.5 Million Financing on Behalf of Neurotrope, Inc.
December 07, 2016
Mintz attorneys completed a $24.5 million financing in a private placement of common stock and warrants exercisable for common stock on behalf of Neutotrope, Inc., a company focused on developing drugs to treat neurodegenerative diseases including Alzheimer's disease.
Muni Disclosure Responsibility Would Shift to Issuers From Underwriters in Draft Bill
December 7, 2016
Mintz Member Chuck Samuels was quoted in this The Bond Buyer article discussing how the draft of a bill would reorient municipal securities disclosure.
Mintz Attorney Susan M. Finegan to Receive 2017 Pinnacle Award from the Greater Boston Chamber of Commerce
December 07, 2016
Susan M. Finegan, Member of the Litigation Practice and Chair of the Pro Bono Committee at Mintz, has been selected as a 2017 Pinnacle Award winner for outstanding achievement in the professions by the Greater Boston Chamber of Commerce.
Pharmacy Cost-Sharing Waivers OK in New Fraud Rule
December 6, 2016
Mintz Special Counsel Ellyn Sternfield is quoted in this Bloomberg BNA Health Care Daily Report article on the final rule from the Department of Health and Human Services Office of Inspector General (OIG).
The impact of recent decisions regarding patent hold-up on the future of standards-setting activities
December 1, 2016
Division Head of the firm’s IP Section Michael Renaud and Special Counsel Sandra Badin authored this Massachusetts Lawyers Journal column on the recent decisions to opt out of standards-setting patent policy introduced by the Institute of Electrical and Electronics Engineers’ (IEEE).
SEC to Face More Pressure on Enforcement Forum Choices
December 1, 2016
Jack Sylvia, Co-chair of the Mintz Securities Litigation Practice, was quoted in this Bloomberg BNA Daily Report for Executives article on Republican lawmakers’ desire to curb the SEC’s authority to use in-house tribunals to bring enforcement actions.
